Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Hollister-Stier, a Year After Getting Bought by Indian Conglomerate, Grows in Spokane
|
Luke Timmerman |
08/20/08 |
|
Seattle
|
|
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News
|
Rebecca Zacks |
08/20/08 |
|
Boston
|
|
Dyax Shares Climb as Lead Drug Candidate Passes Trial
|
Luke Timmerman |
08/18/08 |
|
Boston
|
|
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge
|
Luke Timmerman |
08/14/08 |
|
Boston
|
|
Dendreon Gives Update on Clinical Trials of Prostate Cancer Drug
|
Gregory T. Huang |
08/12/08 |
|
Seattle
|
|
Sonus Obtains License From Bayer to Develop Cancer Drugs
|
Luke Timmerman |
08/07/08 |
|
Seattle
|
|
Amgen Looks to Biomarkers to Boost Its Batting Average in Developing New Drugs
|
Luke Timmerman |
08/07/08 |
|
National
|
|
Alnylam’s In the Money: Expects $500 Million in Bank at Year-End
|
Luke Timmerman |
08/06/08 |
|
Boston
|
|
Genzyme, Isis Start Pivotal Trial for High Cholesterol
|
Luke Timmerman |
08/06/08 |
|
Boston
|
|
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News
|
Rebecca Zacks |
08/06/08 |
|
Boston
|
|
Genzyme Reaching For a Slice From Biogen’s Breadbasket, Multiple Sclerosis Drugs
|
Luke Timmerman |
07/17/08 |
|
Boston
|
|
InnovationRx Launches
|
Wade Roush |
07/14/08 |
|
Boston
|
|
Targeted Genetics Gets Recommended for up to $2.4 Million Government Grant
|
Luke Timmerman |
07/10/08 |
|
Seattle
|
|
CVS Teams with Microsoft, Epix Makes Another Bid at Approval, Thermo Ups RNAi Ante, & More Life Sciences News
|
Rebecca Zacks |
07/02/08 |
|
Boston
|
|
CVS Caremark, Microsoft Form Partnership To Help Consumers Track Their Health Data
|
Luke Timmerman |
06/26/08 |
|
Boston
|
|
InnovationRx: Getting Patients to Take Their Own Medicine, Literally
|
Wade Roush |
06/24/08 |
|
Boston
|
|
Immunogen Sells Stock, Raises $25M
|
Erik Mellgren |
06/23/08 |
|
Boston
|
|
Daily TIPs: Electric Cars, Just Say No to MPG, Climate Plan for Business, DARPA A-OK, and More
|
Neil Savage |
06/20/08 |
Xconomist
|
National
|
|
Vertex Moves Hepatitis Drug Forward, Merrimack Rakes in $60M, Biogen and Icahn Trade Barbs, & More Life Sciences News
|
Rebecca Zacks |
06/12/08 |
|
Boston
|
|
Alnylam Invests $5M in Canadian RNAi Company
|
Luke Timmerman |
06/02/08 |
|
Boston
|
|
FTC Clears Avant-Pfizer Deal for $40M
|
Gregory T. Huang |
05/21/08 |
|
Boston
|
|
Xanthus Sold for $52M
|
Erik Mellgren |
05/16/08 |
|
Boston
|
|
Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments
|
Erik Mellgren |
05/05/08 |
|
Boston
|
|
Cornerstone Buys Critical Therapeutics
|
Wade Roush |
05/02/08 |
|
Boston
|
|
Take Two Blueberry Jelly Beans and Call Me in the Morning: Cambridge Biotech’s Best and Brightest on Show (or Not)
|
Erik Mellgren |
05/02/08 |
|
Boston
|
|
Sirtris Exec Says Acquisition by GlaxoSmithKline is “Great for Boston”
|
Wade Roush |
04/22/08 |
|
Boston
|
|
GlaxoSmithKline Scoops Up Sirtris
|
Wade Roush |
04/22/08 |
|
Boston
|
|
Aileron Raises $10 Million
|
Robert Buderi |
04/15/08 |
|
Boston
|
|
ArQule Gets a New CEO
|
Wade Roush |
04/15/08 |
|
Boston
|
|
Vertex on the Rise, Sirtris on TV, an IPO (Finally) on the Table, and More Life Sciences News
|
Rebecca Zacks |
04/02/08 |
|
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
